Pulmonart

Docetaxel · Sanofi

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pulmonart, covering 2010-02-17 to 2010-02-17. Get the full timeline:

Most recent: Clinical Trial Update: Pulmonart: Docetaxel - Non-Small Cell Lung Cancer (NSCLC) [Phase 2]